Fred Hutch's Dr. Slobodan Beronja and colleagues published new findings that show healthy skin cells can fight off the cancerous tendencies of nearby cells that harbor cancer-causing mutations. Dr. Jeremy Roop, a postdoc conducting HIV research in the McElrath Lab and Computational biology in the Bloom Lab, has been named a Damon Runyan Fellow.
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
March 18, 2016
| by Susan Keown / Fred Hutch News Service
Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.
Vaccine potentially could be used in the majority of breast cancer patients
Dec. 3, 2014
| By Diane Mapes / Fred Hutch News Service
They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. Fred Hutch researchers weigh in and discuss their own breast cancer vaccine-related work.
Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies
April 11, 2011
Research institutions at 27 sites across North America have been selected as part of the Cancer Immunotherapy Trials Network, based at the Fred Hutchinson Cancer Research Center. A new initiative in immunotherapy, CITN unites top academic immunologists to conduct multicenter research on therapies that boost patients’ own immune systems to fight cancer.
Center to lead national, multi-institutional clinical trials effort
Oct. 11, 2010
In an effort to accelerate clinical trials of promising cancer immunotherapies, the National Cancer Institute has awarded a five-year, $17 million grant to the Fred Hutchinson Cancer Research Center Clinical Research Division’s Dr. Mac Cheever to establish a new Cancer Immunotherapy Trials Network.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.